HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Roussel Selected Research

M Roussel Research Topics

Disease

4Multiple Myeloma
01/2016 - 01/2000
2Cognitive Dysfunction
07/2017 - 10/2013
2Neoplasms (Cancer)
12/2010 - 03/2003
2Acidosis
03/2003 - 02/2000
1Brain Diseases (Brain Disorder)
01/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2017
1Disease Progression
09/2015
1Large Granular Lymphocytic Leukemia
05/2014
1Dementia (Dementias)
10/2013
1Memory Disorders (Memory Loss)
10/2013
1Stroke (Strokes)
10/2013
1Myiasis (Myiases)
01/2007
1Cutaneous Leishmaniasis
06/2006
1Thrombocytopenia (Thrombopenia)
05/2005
1Lymphopenia (Lymphocytopenia)
05/2005
1Proteinuria
05/2005
1Leukemia
10/2001
1Strabismus (Squint)
01/2001
1Seizures (Absence Seizure)
01/2001
1Hairy Cell Leukemia
01/2000
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2000
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2000

Drug/Important Bio-Agent (IBA)

2Amyloid (Amyloid Fibrils)IBA
07/2017 - 10/2013
2pomalidomideIBA
01/2016 - 09/2015
2Phosphocreatine (Neoton)IBA
03/2003 - 02/2000
1SymportersIBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2017
1B7-H1 AntigenIBA
01/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2016
1Proteasome InhibitorsIBA
09/2015
1Bortezomib (Velcade)FDA Link
09/2015
1Lenalidomide (CC 5013)FDA Link
09/2015
1Immunomodulating AgentsIBA
09/2015
1Thalidomide (Thalomid)FDA Link
09/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2014
1Interleukin-4 (Interleukin 4)IBA
12/2010
1Ivermectin (Mectizan)FDA Link
01/2007
1Pentamidine (NebuPent)FDA LinkGeneric
06/2006
1EnzymesIBA
05/2005
1CreatinineIBA
05/2005
1Adenosine Triphosphate (ATP)IBA
03/2003
1CyclinsIBA
03/2003
1promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
10/2001
1Proteins (Proteins, Gene)FDA Link
10/2001
1Valproic Acid (Depakote)FDA LinkGeneric
01/2001
1Cyclin D1IBA
01/2000

Therapy/Procedure

3Therapeutics
07/2017 - 05/2014
1Stem Cell Transplantation
11/2013
1Activities of Daily Living (ADL)
10/2013
1Secondary Prevention
10/2013
1Injections
06/2006